
|Articles|June 1, 2003
The American Journal of Managed Care
- June 2003
- Volume 9
- Issue 6
High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Medicare Insulin Savings Model Cuts Costs, Boosts Access, Report Finds
2
Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology
3
Major Bleeding Prevention, Treatment Requires Vigilance in Patients With ET
4
Executive Order on Homelessness Includes Several Policy Shifts: Katherine Koh, MD, MSc
5